OptimizeRx Corp
OPRX
Market Cap$335.47M
Close$
$-2.10
111.3% downside
Current Fair Value
111.3% downsideOvervalued by 111.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $335.47 Million |
|---|---|
| Enterprise Value | $323.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.1 |
| Beta | 1.33 |
| Outstanding Shares | 18,510,834 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -33.89 |
|---|---|
| PEG | 24.52 |
| Price to Sales | 3.72 |
| Price to Book Ratio | 3.1 |
| Enterprise Value to Revenue | 3.09 |
| Enterprise Value to EBIT | -32.97 |
| Enterprise Value to Net Income | -33 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...